<a href="https://www.biocentury.com/article/240963/fda-industry-patient-groups-charting-compassionate-use-policies" target="_blank" rel="noopener noreferrer">“Scaling Compassion” <span id="title">Usdin</span> <span id="author-date">BioCentury, November 2015</span></a>
Visit Site
<a href="https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2385762" target="_blank" rel="noopener noreferrer">“Crowdsourcing Clinical Trials” <span id="title">Darrow</span> <span id="author-date">Minnesota Law Review, January 2014 </span></a>
Visit Site
<a href="https://link.springer.com/article/10.1007/s40290-015-0091-9" target="_blank" rel="noopener noreferrer">“Global Access Programs: A Collaborative Approach for Effective Implementation and Management” <span id="title">Ainge, Aitken, Corbett, De-Keyzer</span> <span id="author-date">Pharmaceutical Magazine, March 2015</span></a>
Visit Site
<a href="https://www.ncbi.nlm.nih.gov/books/NBK92275/" target="_blank" rel="noopener noreferrer">Envisioning a Transformed Clinical Trials Enterprise in the United States; Establishing an Agenda for 2020 Institute of Medicine<span id="title"></span> <span id="author-date">National Academies Press, November 2012</span></a>
Visit Site
<a href="https://www.nature.com/articles/s41587-020-0686-x" target="_blank" rel="noopener noreferrer">Artificial Intelligence, Drug Repurposing, and Peer Review <span id="title">Levin, et al.</span> <span id="author-date">Nature Biotechnology, September 2020</span></a>
Visit Site
<a href="https://pubmed.ncbi.nlm.nih.gov/19815649/" target="_blank" rel="noopener noreferrer">Results from Lepatinib (Tykerb) EAP in HER+ Breast Cancer <span id="title">Capri, et al.</span> <span id="author-date">Oxford University Press, March 2010</span></a>
Visit Site
<a href="https://academic.oup.com/jac/article/50/6/1017/809757" target="_blank" rel="noopener noreferrer">Results of Linezolid EAP in Staphylococcus Aureus Infection <span id="title">Moise, Forrest, Birmingham, Schentag</span><span id="author-date">Journal of Antimicrobial Chemotherapy, August 2002</span></a>
Visit Site
<a href="https://www.nejm.org/doi/full/10.1056/nejmhle1409465" target="_blank" rel="noopener noreferrer">“Practical, Legal, and Ethical Issues in Expanded Access to Investigational Drugs” <span id="title">Darrow, Sarpatwari, Avorn, Kessleheim</span> <span id="author-date">NEJM, January 2015</span></a>
Visit Site
<a href="https://acsjournals.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.24864" target="_blank" rel="noopener noreferrer">Results of Sorafenib (Nexavar) EAP in Kidney Cancer <span id="title">Stadler, et al.</span><span id="author-date">Cancer, March 2010</span></a>
Visit Site
<a href="https://www.nejm.org/doi/full/10.1056/NEJMp1615879" target="_blank" rel="noopener noreferrer">“Reevaluating Eligibility Criteria -Balancing Patient Protection and Participation in Oncology Trials” <span id="title">Beaver, Ison, Pazdur</span><span id="author-date">NEJM, April 2017</span></a>
Visit Site
